Licochalcone A specifically induces cell death in glioma stem cells via mitochondrial dysfunction
Related Experiment Video
Updated: Mar 1, 2026
Detection of Mitochondria Membrane Potential to Study CLIC4 Knockdown-induced HN4 Cell Apoptosis In Vitro
Published on: July 17, 2018
Kenta Kuramoto1, Shuhei Suzuki1,2, Hirotsugu Sakaki1,3
1Department of Molecular Cancer Science Yamagata University School of Medicine Japan.
Abstract:
Glioblastoma multiforme is the most malignant primary intrinsic brain tumor. Glioma stem cells (GSCs) are associated with chemoradiotherapy resistance and the recurrence of glioblastomas after conventional therapy. The targeting of GSCs is potentially an effective treatment for the long-term survival of glioblastoma patients. Licochalcone A, a natural chalconoid from licorice root, exerts anticancer effects; however, its effect on GSCs remains unknown. We found that Licochalcone A induced massive caspase-dependent death in GSCs but not in differentiated GSCs nor normal somatic and neural stem cells. Prior to cell death, Licochalcone A caused mitochondrial fragmentation and reduced the membrane potential and ATP production in GSCs. Thus, Licochalcone A induces mitochondrial dysfunction and shows promise as an anticancer stem cell drug.
Insights
Licochalcone A induces programmed cell death in glioblastoma stem cells (GSCs) by disrupting mitochondria. This natural compound shows promise for targeting GSCs and improving glioblastoma treatment outcomes.
Area of Science:
- Neuro-oncology
- Stem cell biology
- Natural product chemistry
Background:
- Glioblastoma multiforme (GBM) is an aggressive brain tumor.
- Glioma stem cells (GSCs) drive tumor recurrence and treatment resistance.
- Targeting GSCs is crucial for improving patient survival.
Purpose of the Study:
- To investigate the effects of Licochalcone A on GSCs.
- To determine the mechanism of Licochalcone A's action on GSCs.
- To evaluate Licochalcone A as a potential anti-GSC therapeutic.
Main Methods:
- Treatment of GSCs with Licochalcone A.
- Assessment of cell viability and apoptosis.
- Analysis of mitochondrial function (fragmentation, membrane potential, ATP production).
Main Results:
- Licochalcone A induced significant caspase-dependent cell death in GSCs.
- Licochalcone A did not affect differentiated GSCs or normal stem cells.
- Mitochondrial fragmentation, reduced membrane potential, and decreased ATP production were observed in GSCs treated with Licochalcone A.
Conclusions:
- Licochalcone A effectively targets GSCs by inducing mitochondrial dysfunction.
- Licochalcone A demonstrates potential as a novel therapeutic agent against glioblastoma stem cells.
- Further research into Licochalcone A for glioblastoma treatment is warranted.
More Related Videos
10:28Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
Published on: January 10, 2018
07:58An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity
Published on: May 12, 2020